So-called "superficial" bladder tumors. Which classification in 2003? Part 1: Papillary tumors;Les tumeurs urothéliales dites « superficielles » de la vessie. Quelle classification en 2003? Ire partie: Les tumeurs papillaires

Annales de Pathologie

Volumn 23, Issue 1, 2003, Pages 21-33

  Billerey, Claude ^a   Sibony, Mathilde ^b  

^a UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^b HÔPITAL TENON   (France)

Author keywords

Classification; Grading; Muscularis mucosae; pT1; pTa; Stage; Superficial bladder urothelial carcinoma

Indexed keywords

BLADDER CARCINOMA; BLADDER TUMOR; CANCER CLASSIFICATION; CANCER GRADING; CANCER GROWTH; CANCER INFILTRATION; CANCER RECURRENCE; CANCER STAGING; CARCINOMA IN SITU; CONSERVATIVE TREATMENT; HUMAN; HUMAN TISSUE; LAMINA PROPRIA; PAPILLOMA; REPRODUCIBILITY; REVIEW; SUPERFICIAL BLADDER TUMOR; WORLD HEALTH ORGANIZATION; CLASSIFICATION; DIFFERENTIAL DIAGNOSIS; IMMUNOHISTOCHEMISTRY; PATHOLOGY; TRANSITIONAL CELL CARCINOMA;

TUMOR MARKER;

CARCINOMA, TRANSITIONAL CELL; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM STAGING; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 0038726883     PISSN: 02426498     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (59)

1. Kurth K, Denis L, Sylvester R, de Pauw M. The natural history and the prognosis of treated superficial bladder cancer. EORTC GU Group. Prog Clin Biol Res 1992; 378: 1-7.
2. Gattegno B, Chopin D. Tumeurs superficielles de la vessie. Histoire naturelle. Prog Urol 2001; 11: 963-90.
3. Lebret T, Bohin D, Kassardjian Z, Herve JM, Molinie V, Barre P et al. Recurrence, progression and success in stage Ta grade 3 bladder tumors treated with low dose bacillus Calmette-Guerin instillations. J Urol 2000; 163: 63-7.
4. Soloway MS, Sofer M, Vaidya A. Contemporary management of stage T1 transitional cell carcinoma of the bladder. J Urol 2002; 167: 1573-83.
5. Herr HW. Tumour progression and survival in patients with T1G3 bladder tumours: 15-years outcome. Br J Urol 1997; 80: 762-5.
6. Chomé J, Algazi J. Classification et pronostic des tumeurs épithéliales primitives de la vessie. Bull Cancer 1957; 44: 278-92.
7. Bergkvist A, Ljungqvist A, Moberger G. Classification of bladder tumours based on the cellular pattern. Preliminary report of a clinical-pathological study of 300 cases with a minimum follow-up of eight years. Acta Chir Scand 1965. 130: 371-378.
8. Mostofi FK, Sobin LH, Torloni H. International histological classification of tumours. Histological typing of urinary bladder tumours. Ed OMS Genève 1973.
9. Malmström PU, Busch C, Norlen BJ. Recurrence, progression and survival in bladder cancer. A retrospective analysis of 232 patients with ≥ 5-years follow-up. Scand J Urol Nephrol 1987; 21: 185-95.
10. Jordan AM, Weingarten J, Murphy WM. Transitional cell neoplasm of the urinary bladder. Can biologic potential be predicted from histologic grading? Cancer 1987; 60: 2766-74.
11. Murphy WM, Beckwith JB, Farrow GM. Tumors of the kidney, bladder, and related urinary structures. Atlas of tumor pathology, third series, fascicle n° 11: Washington DC, Armed Forces Institute of Pathology, 1994.
12. Epstein JI, Amin MB, Reuter VR, Mostofi FK. The world Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Am J Surg Pathol 1998, 22: 1435-48.
13. Mostofi FK, Davis CJ, Sesterhenn IA (1999) World Health Organization. International histological classification of tumours. Histological typing of urinary bladder tumours. Second Edition. Ed. Spinger-Verlag, Berlin Heidelberg.
14. Alsheikh A, Mohamedali Z, Jones E, Masterson J, Gilks CB. Comparison of the WHO/ISUP classification and cytokeratin 20 expression in predicting the behavior of low-grade papillary urothelial tumors. Mod Pathol 2001; 14: 267-72.
15. Holmang S, Hedelin H, Anderstrom C, Holmberg E, Busch C, Johansson SL. Recurrence and progression in low grade papillary urothelial tumors. J Urol 1999; 162: 702-7.
16. Desai S, Lim SD, Jimenez RE, Chun T, Keane TE, McKenney JK et al. Relationship of cytokeratin 20 and CD44 protein expression with WHO/ISUP grade in pTa and pT1 papillary urothelial neoplasia. Mod Pathol 2000; 13, 1315-23.
17. Cheng L, Bostwick DG. World Health Organization and International Society of Urological. Pathology classification and two-number grading system of bladder tumors. Cancer 2000; 88: 1513-16.
18. Holmang S, Andius P, Hedelin H, Wester K, Busch C, Johansson SL. Stage progression in Ta papillary tumors: relationship to grade, immunohistochemical expression of tumor markers, mitotic frequency and ploidy. J Urol 2001; 165: 1124-8.
19. Guillou L. Données nouvelles dans la classification de tumeurs urothéliales de la vessie. Ann Pathol 1999; 19: S103-7.
20. Billerey C, Sibony M. Anatomie pathologique des tumeurs superficielles de la vessie. Prog Urol 2001; 11: 807-63.
21. Cheng L, Neumann RM, Bostwick DG. Papillary urothelial neoplasms of low malignant potential. Clinical and biologic implications. Cancer 1999; 86: 2102-8.
22. Mazerolles C, Auvigne I. Nouvelle classification des néoplasies urothéliales. Bull Div Fr AIP. 2002; 35: 15-20.
23. Helpap B, Köllermann J. Assessment of basal cell status and proliferative patterns in flat and papillary urothelial lesions: A contribution to the new WHO classification of urothelial tumors of the urinary bladder. Hum Pathol; 2000: 31: 745-50.
24. Alvarez Kindelan J, Lopez Beltran A, Requena Tapia MJ. Urothelial papillary neoplasms of low malignant potential. Retrospective studies. Actas Urol Esp 2000; 24: 743-8.
25. Bostwick DG, Montironi R, Lopez-Beltran A, Cheng L. Urothelial bladder tumors: The Ancona 2001 refinemento of the WHO 1973 classification. USCAP Chicago Mars 2002.
26. Witjes JA, van Balken MR, van de Kaa CA. The pronostic value of a primary inverted papilloma of the urinary tract. J Urol; 1997, 158: 1500-5.
27. Cheng L, Darson M, Cheville JC, Neumann RM, Zincke H, Nehra A et al. Urothelial papilloma of the bladder. Clinical and biologic implications. Cancer. 1999 Nov 15; 86 (10): 2098-101.
28. Sorensen FB, Sasaki M, Fukuzawa S, Yamabe H, Olsen S et al. Qualitative and quantitative histopathology in transitional cell carcinomas of the urinary bladder. An international investigation of intra and interobserver reproductibility. Lab Invest 1994,70, 242-54.
29. Montironi R, Scarpelli, Ansuini G, Pisani E, Del Fiasco S, Maruizzi GM. Quantitative evaluation of the progressive nuclear abnormality in urothelial papillary lesions. Appl Pathol 1986; 4: 65-73.
30. Blomjous CEM, Vos W, Schipper NW, Uyterlinde AM, Baak JPA, de Voogt HJ et al. The prognostic significance of selective nuclear morphometry in urinary bladder carcinoma. Hum Pathol 1990; 21: 409-413.
31. Jarkrans T, Vasco J, Bengtsson E, Choi HK, Malmstrom PU, Wester K, et al. Grading of transitional cell bladder carcinoma by image analysis of histological sections. Anal Cell Pathol 1995; 8: 135-58.
32. Cohen MB, Waldman FM, Carroll PR, Kerschmann R, Chew K, Mayall BH. Comparison of five histopathologic methods to assess cellular proliferation in transitional cell carcinoma of the urinary bladder. Hum Pathol 1993; 24: 772-778
33. Bol MG, Baak JP, de Bruin PC, Rep S, Marx W, Bos S et al. Improved objectivity of grading of T (A, 1) transitional cell carcinomas of the urinary bladder by quantitative nuclear and proliferation related features. J Clin Pathol 2001; 54: 854-9.
34. Billerey C, Vieillefond A. Facteurs pronostiques et marqueurs tumoraux utiles dans les carcinomes urothéliaux de la vessie. Ann Pathol 1999, 19 (suppl 5) S107-109.
35. Harnden P, Mahmood N, Southgate J. Expression of cytokeratin 20 redefines urothelial papillomas of the bladder. Lancet 1999: 353, 974-7.
36. e édition. UICC, Genève. Paris: Springer-Verlag, 1997.
37. Hasui Y, Osada Y, Kitada S, Nishi S. Significance of invasion to invasion to the muscularis mucosae on the progression of superficial bladder cancer. Urology 1994; 43: 782-6.
38. Angulo JC, Lopez JI, Grignon DJ, Sanchez-Chapado M. Muscularis mucosa differentiates two populations with different prognosis in stage T1 bladder cancer. Urology 1995; 45: 47-53.
39. Holmang S, Hedelin H, Anderstrom C, Holmberg E, Johansson SL. The importance of the depth of invasion in stage T1 bladder cancer: a prospective cohort study. J Urol 1997; 157: 800-4.
40. Bernardini S, Billerey C, Martin M, Adessi GL, Wallerand H, Bittard H. The predictive value of muscularis mucosae invasion and p53 over expression on progression of stage T1 bladder carcinoma. J Urol 2001, 165: 42-6.
41. Jimenez RE, Keane TE, Hardy HT, Amin MB. pT1 urothelial carcinoma of the bladder: Criteria for diagnosis, pitfalls and clinical implications. Adv Anat Pathol 2000; 7: 13-25.
42. Younes M, Sussman J, True LD. The usefulness of the level of the muscularis mucosae in the staging of invasive transitional cell carcinoma of urinary bladder. Cancer 1990; 66: 543-8.
43. Platz CE, Cohen MB, Jones MP, Olson DB, Lynch CF. Is microstaging of early invasive cancer of the urinary bladder possible or useful? Mod Pathol 1996; 9: 1035-9.
44. Hermann GG, Horn T, Steven K. the influence of the level of lamina propria invasion and the prevalence of p53 nuclear accumulation on survival in stage T1 transitional cell bladder cancer. J Urol 1998; 159: 91-4.
45. Smits G, Schaafsma E, Kiemeney L, Caris C, Debruyne F, Witjes JA. Microstaging of pT1 transitional cell carcinoma of the bladder: identification of subgroups with distinct risks of progression. Urology 1998; 52: 1009-13.
46. Weaver MG, Abdul-Karim FW. The prevalence and character of the muscularis mucosae of the human urinary bladder. Histopathology 1990; 17: 563-6.
47. Ro JY, Ayalla AG, El-Naggar A. Muscularis mucosae of the urinary bladder. Importance for the staging and treatment. Am J Surg Pathol 1987; 11: 668-73.
48. Cheng L, Weaver AL, Neumann RM, Scherer BG, Bostwick DG. Substaging of T1 bladder carcinoma based on the depth of invasion as measured by micrometer. Cancer 1999; 86: 1035-43.
49. Steg A, Allouch G, Deslignières S. Les facteurs de risque des tumeurs de vessie au stade A. Description et caractère d'un nouveau paramètre. Sem Hôp 1980; 56: 738-43.
50. Billerey C, Boccon-Gibod L, et les anatomo-pathologistes du CCAFU. Etude des variations interpathologistes dans l'évaluation du grade et du stade des tumeurs vésicales. Analyse par 12 pathologistes de 110 tumeurs classées initialement pT1. Prog Urol 1996; 6: 49-57.
51. Pathologists of the French Association of Urology Cancer Committee. Lamina propria microinvasion of bladder tumors, incidence on stage allocation (pTa vs pT1): recommended approach. World J Urol 1993; 11: 161-4.
52. Amin MB, Gomez JA, Young RH. Urothelial transitional cell carcinoma with endophytic growth patterns: a discussion of patterns of invasion and problems associated with assessment of invasion in 18 cases. Am J Surg Pathol 1997; 21: 1057-68.
53. Young RH, Oliva E. Transitional cell carcinomas of the urinary bladder that may be underdiagnosed. A report of four invasive cases exemplifying the homology between neoplastic and non-neoplastic transitional cell lesions. Am J Surg Pathol 1996; 20: 1448-54.
54. Drew PA, Furman J, Civantos F, Murphy WM. The nested variant of transitional cell carcinoma: an aggressive neoplasm with innocuous histology. Mod Pathol 1996; 10: 989-94.
55. Billerey C, Martin L, Bittard H, Adessi GL, Carbillet JP. The nested variant of urothelial carcinoma of the urinary bladder. Report of five cases and review of literature. J Urol Pathol 1999; 11: 89-100.
56. Philip AT, Amin MB, Tamboli P, Lee TJ, Hill CE, Ro JY. Intravesical adipose tissue: a quantitative study of its presence and location with implications for therapy and prognosis. Am J Surg Pathol 2000; 24: 1286-90.
57. Ramani P, Birch BRP, Harland SJ, Parkinson MC. Evaluation of endothelial markers in detecting blood and lymphatic channel invasion in pT1 transitional carcinoma of bladder. Histopathology 1991, 19: 551-4.
58. Alampi G, Gelli C, Mestichelli M, Brizio R, Piccaluga A. Distribution of basement membrane antigens in bladder carcinomas: an additional prognostic parameter. Immunohistochemical study. Arch Anat Cytol Pathol 1989; 37: 224-30.
59. Schapers RF, Pauwels RP, Havenith MG, Smeets AW, van den Brandt PA, Bosman FT. Prognostic significance of the type IV collagen and laminin immunoreactivity in urothelial carcinomas of the bladder. Cancer 1990; 15: 2583-8.